PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $209,000 | -19.0% | 29,815 | +6.1% | 0.00% | -25.0% |
Q2 2021 | $258,000 | -31.2% | 28,105 | -27.1% | 0.00% | -33.3% |
Q1 2021 | $375,000 | -3.1% | 38,549 | +2.1% | 0.01% | 0.0% |
Q4 2020 | $387,000 | +4.0% | 37,748 | +2.4% | 0.01% | -14.3% |
Q3 2020 | $372,000 | +38.3% | 36,851 | +43.0% | 0.01% | +16.7% |
Q2 2020 | $269,000 | +86.8% | 25,769 | +51.4% | 0.01% | +50.0% |
Q1 2020 | $144,000 | +65.5% | 17,015 | +71.8% | 0.00% | +100.0% |
Q4 2019 | $87,000 | -14.7% | 9,905 | +4.0% | 0.00% | 0.0% |
Q3 2019 | $102,000 | +18.6% | 9,521 | +40.3% | 0.00% | 0.0% |
Q2 2019 | $86,000 | -65.7% | 6,784 | +4.7% | 0.00% | -66.7% |
Q1 2019 | $251,000 | +146.1% | 6,477 | +28.9% | 0.01% | +100.0% |
Q4 2018 | $102,000 | -52.1% | 5,023 | +7.9% | 0.00% | -40.0% |
Q3 2018 | $213,000 | +634.5% | 4,656 | +1832.0% | 0.01% | +400.0% |
Q3 2017 | $29,000 | +20.8% | 241 | -11.7% | 0.00% | 0.0% |
Q2 2017 | $24,000 | +50.0% | 273 | -35.5% | 0.00% | – |
Q1 2017 | $16,000 | – | 423 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
Eversept Partners, LP | 58,251 | $491,638 | 0.12% |